USP22 and osteosarcoma: Furthermore, we examined the effect of USP22 on osteosarcoma cell apoptosis using flow cytometry and found that USP22 knockdown significantly increased 143B cell apoptosis compared with that in the shNC treatment group (Figure 2I).